Evidence map›Paper›PMID 32210679›Full record

ArticleSaudi journal of biological sciences2020

Investigating the antiangiogenic potential of

Muhammad Farooq, Nael Abutaha, Shahid Mahboob, Almohannad Baabbad, Nawaf D Almoutiri, Mohammad Ahmed A M Wadaan

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Food science & nutrition · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. ExploringSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Antihypertensive and Vasorelaxant Effects ofCardiovascular & hematological disorders drug targets · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Muhammad FarooqCollege of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia.
Nael AbutahaCollege of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia.
Shahid MahboobDepartment of Zoology, College of Science, King Saud University, 11451 Riyadh, Saudi Arabia.
Almohannad BaabbadCollege of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia.
Nawaf D AlmoutiriCollege of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia.
Mohammad Ahmed A M WadaanCollege of Science, Department of Zoology, King Saud University, 11451 Riyadh, Saudi Arabia.
King Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent trends in anticancer therapy is to use therapeutic agents which not only kill the cancer cell, but are less toxic to surrounding normal cells/tissue. One approach is to cut the nutrient supply to growing tumor cells, by blocking the formation of new blood vessels around the tumor. As the phytochemicals and botanical crude extracts have proven their efficacy as natural antiangiogenic agents with minimum toxicities, there is need to explore varieties of medicinal plants for novel antiangiogenic compounds.

Indexed as

AngiogenesisDevelopmental toxicityPhytochemical screeningRumex vasicarius L.Zebrafish embryos

Identifiers

PMID32210679
PMCPMC6997907
OpenAlexW2992524761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.